DERM2026 Posters

Dupilumab in Prurigo Nodularis: 3-Month Follow-up Insights into GLOBOSPIN, A Global Observational Study Firouzeh Niakosari, Wei Jing Loo, Linfeng Li, Saeko Nakajima, Erin X. Wei, Kristi B. Hawley, Anna Compagnoni, Joseph Zahn, Kwinten Bosman < PREVIOUS POSTER NEXT POSTER > POSTER 49

Treatment of Plaque Psoriasis Involving High-Impact Sites with Icotrokinra, a Targeted Oral Peptide: Pooled Analyses of 4 Phase 3 Placebo-Controlled Trials Jennifer Soung, April W. Armstrong, Ronald B. Vender, Josep Riera-Monroig, Michael Sebastian, Ofelia Reyes-Servin, Bassey Effiom Edem, Ming-Chun Hsu, Shu Li, Ya-Wen Yang, Linda Stein Gold < PREVIOUS POSTER NEXT POSTER > POSTER 50

Real-World Characterization of Patients Initiating Advanced Therapies for Moderate-to-Severe Psoriasis Hsien-yen Chang, Chang Xu, Alexander Litvintchouk, Christopher Russo, Steve Feldman, Timothy Fitzgerald < PREVIOUS POSTER NEXT POSTER > POSTER 51

Inefficiencies of Off-Label Therapy in the Prevention of Generalized Pustular Psoriasis (GPP) Flares: Real-World Evidence from Europe Laurent Misery, Denis Jullien, Manuelle Viguier, Richard B. Warren, Christopher E.M. Griffiths, Michael Sticherling, Bhargav Lakshminarasimhan, Nichiren Pillai, Shah Alam Khan, Elke M.G.J. de Jong, Anna Balato, Stefano Piaserico < PREVIOUS POSTER NEXT POSTER > POSTER 52

The Burden and Management of Flares Among Pregnant Patients with Generalized Pustular Psoriasis (GPP): Real-Worlda Evidence (RWE) from the Global SCRIPTOR Study Laurent Misery, Denis Jullien, Manuelle Viguier, Richard B. Warren, Christopher Griffiths, Latha R. Selvarajah, Azura Mohd Affandi6 Renata Magalhães, Anber Tanaka, Slaheddine Marrakchi, Wen-Hung Chung, Tsen-Fang Tsai, Bhargav Lakshminarasimhan, Nichiren Pillai, Shah Alam Khan, Rafael Sani Simoes, Mark G. Lebwohl, Xing

Characterization of Generalized Pustular Psoriasis (GPP) Severity via Individual GPP Physician Global Assessment (GPPGA) Components During a Non-Flaring Period: Baseline Data from EFFISAYIL 2 Arash Mostaghimi, Milan J. Anadkat, James G. Krueger, Akimichi Morita, Joseph F. Merola, Jason Guercio, Ming Tang, Christian Thoma, Mark G. Lebwohl < PREVIOUS POSTER NEXT POSTER > POSTER 54

Generalized Pustular Psoriasis: A Systematic Literature Review of Mortality and Comorbidity Data Mark Lebwohl, Bruce Strober, Siew Eng Choon, Lluís Puig, Richard Warren, Akimichi Morita, Nichiren Pillai, Bhargav Lakshminarasimhan, Shah Alam Khan, Rafael Sani Simoes, Min Zheng < PREVIOUS POSTER NEXT POSTER > POSTER 55

Efficacy and Safety of Brodalumab in High BMI Participants With Moderate-to-Severe Plaque Psoriasis: The Patient Journey Mark G. Lebwohl, MD; Eingun James Song, MD, FAAD; Tina Bhutani, MD, MAS, FAADC; Wilson Liao, MD; April W. Armstrong, MD, MPH < PREVIOUS POSTER NEXT POSTER > POSTER 56

Once-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002) Melinda Gooderham, Vivian Laquer, Jianzhong Zhang, Joanna Narbutt, Akimichi Morita, Paula Luna, Wenwen Zhang, Warren Winkelman, Edith Angellotti, Kim Papp, April Armstrong < PREVIOUS POSTER NEXT POSTER > POSTER 57

Bimekizumab On-Treatment Remission as Defined by the National Psoriasis Foundation: 1-Year Results versus Ustekinumab and Secukinumab in Patients with Moderate-to-Severe Plaque Psoriasis April Armstrong, Lourdes Pérez-Chada, Mark Lebwohl, Deepak M.W. Balak, George M. Lewitt, Richard B. Warren, Richard G. Langley, Diamant Thaçi, George Han, Heather Herr, Balint Szilagyi, Sarah Kavanagh, Andrew Blauvelt < PREVIOUS POSTER NEXT POSTER > POSTER 58

APEX: Guselkumab Response and Inhibition of Structural Damage Progression in Active Psoriatic Arthritis by Participant Baseline Characteristics Philip J Mease, Christopher T Ritchlin, Laura C Coates, Alexa P Kollmeier, Bei Zhou, Yusang Jiang, April W. Armstrong, Karissa Lozenski, Soumya D. Chakravarty, Proton Rahman < PREVIOUS POSTER NEXT POSTER > POSTER 59

Video Education to Promote Awareness about Dysplastic Nevi Philip J Mease, Christopher T Ritchlin, Laura C Coates, Alexa P Kollmeier, Bei Zhou, Yusang Jiang, April W. Armstrong, Karissa Lozenski, Soumya D. Chakravarty, Proton Rahman Kendall Crum, OMS-III; Christy Merrick, DNP; Rebecca Tung, MD < PREVIOUS POSTER NEXT POSTER > POSTER 60

Clinical Evaluation of Skin Moisturization, Dryness, Roughness and TEWL Following a Single Application of a Novel Panthenol plus Bisabolol-Enhanced Cream and Lotion Julie C. Harper, MD, Mara C. Weinstein Velez, MD, Joe Gorelick, MSN, FNP-C, Michael Folsom-Kovarik, MS, April Armstrong, MD, MPH < PREVIOUS POSTER NEXT POSTER > POSTER 61

Assessing the Mildness of Cleansers Using the Corneosurfametry Method Sindhu Garimella, MS; Thu Q. Nguyen, PhD; Christine Emesiani, PharmD; Matthew Meckfessel, PhD < PREVIOUS POSTER NEXT POSTER > POSTER 62

Efficacy of an Innovative Cream on Biomarkers for Aging in Mature, Fragile Skin Glynis Ablon, MD, FAAD; Alan Widgerow, MBBCh, MMed, FCS, FACS; Thu Q. Nguyen, PhD; Sindhu Garimella, MS; Christine Emesiani, PharmD; Matthew Meckfessel, PhD < PREVIOUS POSTER NEXT POSTER > POSTER 63

Clinical Evaluation of a Thiamidol-based Cream for Targeted Areas of Body Hyperpigmentation Pearl Grimes, MD, Cheri Frey, MD, Edward (Ted) Lain, MD, MBA, Seemal R. Desai, MD < PREVIOUS POSTER NEXT POSTER > POSTER 64

Clinical Evaluation of a Thiamidol-based Cream for Treatment of Periorbital Hyperpigmentation Seemal R. Desai, MD, Nada Elbuluk, MD, Edward (Ted) Lain, MD, MBA < PREVIOUS POSTER NEXT POSTER > POSTER 65

Consistency of Repigmentation Response and Safety With Ruxolitinib Cream in Patients With Nonsegmental Vitiligo: Analysis of 6 Clinical Trials Seemal R. Desai, MD, Dan Sturm, PharmD, Xavier Diaz, PharmD, Haobo Ren, PhD, David Rosmarin, MD < PREVIOUS POSTER BACK TO START > POSTER 66